pI: 5.8973 |
Length (AA): 477 |
MW (Da): 53331 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
4 | 477 | 1v8b (A) | 4 | 479 | 89.00 | 0 | 1 | 2.13 | -1.74 |
4 | 477 | 1v8b (A) | 4 | 479 | 89.00 | 0 | 1 | 2.09501 | -1.19 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intraerythrocytic - 6 hs, intraerythrocytic - 12 hs, intraerythrocytic - 18 hs, intraerythrocytic - 24 hs. | Zhu L |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intraerythrocytic - 30 hs, intraerythrocytic - 40 hs, intraerythrocytic - 48 hs. | Zhu L |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intraerythrocytic - 36 hs. | Zhu L |
Zhu L | New insights into the Plasmodium vivax transcriptome using RNA-Seq. |
Ortholog group members (OG5_127233)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G13940 | adenosylhomocysteinase 1 |
Arabidopsis thaliana | AT3G23810 | adenosylhomocysteinase 2 |
Babesia bovis | BBOV_I001740 | adenosylhomocysteinase (S-adenosyl-L-homocysteinehydrolase) |
Brugia malayi | Bm1_48165 | Adenosylhomocysteinase |
Candida albicans | CaO19.11392 | Putative S-adenosyl-L-homocysteine hydrolase |
Candida albicans | CaO19.3911 | Putative S-adenosyl-L-homocysteine hydrolase |
Caenorhabditis elegans | CELE_K02F2.2 | Protein AHCY-1 |
Cryptosporidium hominis | Chro.30017 | adenosylhomocysteinase |
Cryptosporidium parvum | cgd3_80 | S-adenosylhomocysteinase |
Dictyostelium discoideum | DDB_G0278037 | hypothetical protein |
Dictyostelium discoideum | DDB_G0278035 | hypothetical protein |
Dictyostelium discoideum | DDB_G0267418 | AdoHyc hydrolase |
Drosophila melanogaster | Dmel_CG11654 | Adenosylhomocysteinase at 13 |
Echinococcus granulosus | EgrG_000076900 | adenosylhomocysteinase |
Entamoeba histolytica | EHI_068250 | adenosylhomocysteinase, putative |
Echinococcus multilocularis | EmuJ_000076900 | adenosylhomocysteinase |
Homo sapiens | ENSG00000101444 | adenosylhomocysteinase |
Leishmania braziliensis | LbrM.35.4150 | S-adenosylhomocysteine hydrolase |
Leishmania braziliensis | LbrM.35.4140 | S-adenosylhomocysteine hydrolase |
Leishmania donovani | LdBPK_364100.1 | S-adenosylhomocysteine hydrolase |
Leishmania infantum | LinJ.36.4100 | S-adenosylhomocysteine hydrolase |
Leishmania major | LmjF.36.3910 | S-adenosylhomocysteine hydrolase |
Leishmania mexicana | LmxM.36.3910 | S-adenosylhomocysteine hydrolase |
Loa Loa (eye worm) | LOAG_04848 | adenosylhomocysteinase |
Mycobacterium leprae | ML0771 | putative S-adenosyl-L-homocysteine hydrolase SahH |
Mus musculus | ENSMUSG00000027597 | S-adenosylhomocysteine hydrolase |
Mus musculus | 102643284 | adenosylhomocysteinase-like |
Mycobacterium tuberculosis | Rv3248c | Probable adenosylhomocysteinase SahH (S-adenosyl-L-homocysteine hydrolase) (adohcyase) |
Mycobacterium ulcerans | MUL_2592 | S-adenosyl-L-homocysteine hydrolase |
Neospora caninum | NCLIV_047660 | hypothetical protein |
Oryza sativa | 4350455 | Os11g0455500 |
Plasmodium berghei | PBANKA_1235600 | adenosylhomocysteinase, putative |
Plasmodium falciparum | PF3D7_0520900 | adenosylhomocysteinase |
Plasmodium knowlesi | PKNH_1012000 | adenosylhomocysteinase, putative |
Plasmodium vivax | PVX_080200 | adenosylhomocysteinase(S-adenosyl-L-homocystein e hydrolase), putative |
Plasmodium yoelii | PY02893 | adenosylhomocysteinase |
Saccharomyces cerevisiae | YER043C | adenosylhomocysteinase |
Schistosoma japonicum | Sjp_0009180 | ko:K01251 adenosylhomocysteinase [EC3.3.1.1], putative |
Schistosoma mansoni | Smp_028440.1 | adenosylhomocysteinase |
Schmidtea mediterranea | mk4.041384.00 | Adenosylhomocysteinase |
Schmidtea mediterranea | mk4.002401.00 | Adenosylhomocysteinase |
Schmidtea mediterranea | mk4.007090.00 | Adenosylhomocysteinase |
Schmidtea mediterranea | mk4.038032.00 | Adenosylhomocysteinase |
Trypanosoma brucei gambiense | Tbg972.11.10770 | S-adenosylhomocysteine hydrolase, putative |
Trypanosoma brucei | Tb927.11.9590 | S-adenosylhomocysteine hydrolase, putative |
Trypanosoma congolense | TcIL3000.11.10090 | S-adenosylhomocysteine hydrolase, putative |
Trypanosoma congolense | TcIL3000_0_20500 | S-adenosylhomocysteine hydrolase, putative |
Trypanosoma cruzi | TcCLB.511589.200 | S-adenosylhomocysteine hydrolase, putative |
Trypanosoma cruzi | TcCLB.511229.50 | S-adenosylhomocysteine hydrolase, putative |
Toxoplasma gondii | TGME49_225050 | adenosylhomocysteinase, putative |
Toxoplasma gondii | TGME49_326800 | S-Adenosyl homocysteine hydrolase |
Theileria parva | TP03_0160 | S-adenosyl-L-homocysteine hydrolase, putative |
Trichomonas vaginalis | TVAG_210320 | adenosylhomocysteinase, putative |
Trichomonas vaginalis | TVAG_405240 | adenosylhomocysteinase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu3307 | Mycobacterium tuberculosis | essential | nmpdr |
Tb11.01.1350 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.1350 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.1350 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.1350 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_K02F2.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_K02F2.2 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_K02F2.2 | Caenorhabditis elegans | larval lethal | wormbase |
YER043C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1235600 | Plasmodium berghei | Slow | plasmo |
TGME49_225050 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_326800 | Toxoplasma gondii | Essentiality uncertain | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.8
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Trypanosoma cruzi | S-adenosylhomocysteine hydrolase, putative | Compounds | References |
Plasmodium falciparum | adenosylhomocysteinase | Compounds | References |
Trypanosoma cruzi | S-adenosylhomocysteine hydrolase, putative | Compounds | References |
Homo sapiens | adenosylhomocysteinase | Compounds | References |
Mus musculus | S-adenosylhomocysteine hydrolase | Compounds | References |
Rattus norvegicus | Adenosylhomocysteinase | Compounds | References |